In this provocative conversation on Rebranding Mental Health, Iman and Kurt peel back the layers of modern psychiatry’s love affair with medication. How did pills become the first—and sometimes only—response to human distress?

We’ll start by tracing the shift from talk therapy to chemical treatments, examining why antidepressant use has soared over 400% in just a few decades. You’ll hear the promises: quick relief, insurance coverage, the allure of scientific authority. And you’ll hear the trade-offs: overprescription, side effects, and the quiet inflation of psychiatric diagnoses.

Next, we’ll get honest about what meds can—and can’t—do. They can stabilize you enough to step into therapy or get through a crisis. But they can’t heal trauma, teach skills, or cultivate connection. Are we treating pain—or simply silencing signals that something deeper needs tending?

Finally, we’ll explore the complex dance between biology, capitalism, and personal choice. From pharmaceutical marketing to the DSM’s double life as both a diagnostic and billing tool, we’ll ask: Are we genuinely informed about what we’re taking—and why?

This episode isn’t about demonizing medication. It’s about reclaiming nuance. About seeing pharmaceuticals as one tool—not the whole toolbox.

If you’ve ever wondered whether a chemical imbalance tells the whole story, or how to honor both biology and biography in mental health care, this is your invitation to think critically—and compassionately.

🎧 Tune in and explore the power of clear information, real consent, and the radical possibility of choosing what healing looks like for you.

https://www.bloomingminds.org

https://www.instagram.com/imanlkhan/

https://www.facebook.com/bloomingminds.org

"Rebranding Mental Health: A Movement, Not a Label."